Adverum Biotechnologies - 53 Year Dividend History | ADVM
Historical dividend payout and yield for Adverum Biotechnologies (ADVM) since 1971. The current TTM dividend payout for Adverum Biotechnologies (ADVM) as of December 20, 2024 is $0.00. The current dividend yield for Adverum Biotechnologies as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.112B |
$0.004B |
|
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
